|
|
| | Ritipenemacoxil Basic information |
| Product Name: | Ritipenemacoxil | | Synonyms: | FCE 22891;[14C]-FCE22891;4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-, (acetyloxy)methyl ester, (5R,6S)- | | CAS: | 87238-52-6 | | MF: | C13H16N2O8S | | MW: | 360.34 | | EINECS: | | | Product Categories: | | | Mol File: | 87238-52-6.mol |  |
| | Ritipenemacoxil Chemical Properties |
| Boiling point | 656.0±55.0 °C(Predicted) | | density | 1.57±0.1 g/cm3(Predicted) | | pka | 13.31±0.50(Predicted) |
| Toxicity | LD50 in male, female mice, male, female rats (mg/kg): 4363, 6167, >5000, >5000 orally (Brughera) |
| | Ritipenemacoxil Usage And Synthesis |
| Uses | Ritipenem acoxil (FCE 22891; RIPM-AC) is an oral active beta-lactamase antibiotic and can be used for study of bacterial pneumonia[1]. | | References | [1] Saito A, et al. [A comparative study on the efficacies of ritipenem acoxil and cefotiam hexetil in bacterial pneumonia by the double-blind method]. Jpn J Antibiot. 1996 Feb;49(2):144-74. Japanese. PMID:8721077 |
| | Ritipenemacoxil Preparation Products And Raw materials |
|